Advertisement Australian TGA grants Anlit GMP certification - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Australian TGA grants Anlit GMP certification

Anlit, Israel-based developer of quality consumer vitamins, minerals and dietary supplements for children, has received GMP certification from the Australian Therapeutic Goods Administration (TGA), the governmental authority charged with regulating therapeutic goods for the protection of public health and safety.

The company secured the certification for its new supplement format designed specifically for children called Kidi Bites.

Anlit Marketing VP Shai Karlinski said the company approached this certification as a strategic move, designed to bring its products to the global forefront of quality and excellence.

"Anlit had to follow a fast learning curve, forging beyond the former food supplement paradigms and adopting new pharma concepts and processes," Karlinski said.

Securing TGA approval is part of the company’s strategy for pursuing the highest and most stringent quality standards, paving the way to partnerships with global pharmaceutical companies that are seeking diversification of their product portfolio with unique food supplements.

The Kidi Bites Technology produces tasty supplements focused on kids’ preferences and providing the essential health benefits children need.

The company said that the delicious matrix, with chocolaty flavor and texture, overcomes children’s typical reluctance to taking nutritional supplements.